Sequent Scientific Ltd. reported an 18.7% YoY revenue growth to Rs 3,908 million for Q3 FY25, driven by strong performance in Formulations and API, and anticipates completion of a strategic merger with Viyash Life Sciences by December 2025.
AI Assistant
Sequent Scientific Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.